APEA Neuro Pharmacology | Latest 2025 Revised Questions & Correct Detailed Answers Verified

RM
HARM
LATEST
LATEST
Package
20252025
REVISED
Deal
REVISED
(2026/2027)1
EXAMEXAM
QUESTIONS
ofQUESTIONS
37 ANDAND
CORRECT
CORRECT
DETAILED
DETAILED
ANSWERS
ANSWERS
(VERIFIED
(VERIFIED
COMPLETE
COMPLETE
SOLUTION)
SOLUTION)
ALREADY
ALREADY
PASSED
PASSED
SCORE
SCORE
A+.pdf
A+Package




APEA- NEURO PHARM LATEST 2025
REVISED EXAM QUESTIONS AND
CORRECT DETAILED ANSWERS
(VERIFIED COMPLETE SOLUTION)
ALREADY PASSED SCORE A+



restless leg syndrome and Parkinson disease.
Pramipexole (Mirapex), a dopamine agonist, is indicated in the treatment of:
insomnia and parasomnia disorders.
Parkinson disease and sleep-related eating disorders.
REM sleep behavior disorder and multiple sclerosis.
restless leg syndrome and Parkinson disease.




a 43-year-old woman with hypothyroidism.
The patient who requires the LEAST cautionary measures when treated with
carbidopa/levodopa (Sinemet) is:
a 43-year-old woman with hypothyroidism.
a 45-year-old retired marine with secondary parkinsonism and a history of post-
traumatic stress disorder.



-EXAM
NEURO
QUESTIONS
Exam
PHARM
Q&A
LATEST
(2026/2027)
AND CORRECT
2025 REVISED
| Complete
DETAILED
EXAM
StudyANSWERS
QUESTIONS
Guide & Verified
(VERIFIED
ANDQuestions
CORRECT
COMPLETE
with
DETAILED
Correct
SOLUTION)
AnswersAPEA-
ANSWERS
ALREADY
(VERIFIED
NEURO
PASSED
PHARM
COMPLETE
SCORE
LATEST
A+.pdf=Package
SOLUTION)
2025 REVISED
ALREADY
DealEXAM
(2026/2027)
PASSED
QUESTIONS
SCOREA

,RM
HARM
LATEST
LATEST
Package
20252025
REVISED
Deal
REVISED
(2026/2027)2
EXAMEXAM
QUESTIONS
ofQUESTIONS
37 ANDAND
CORRECT
CORRECT
DETAILED
DETAILED
ANSWERS
ANSWERS
(VERIFIED
(VERIFIED
COMPLETE
COMPLETE
SOLUTION)
SOLUTION)
ALREADY
ALREADY
PASSED
PASSED
SCORE
SCORE
A+.pdf
A+Package




a 50-year-old woman with a history of obstructive sleep apnea.
a 55-year-old man with history a of myocardial infarction with residual atrial
arrhythmia.




tardive dyskinesia.
Benztropine (Cogentin), an anticholinergic, is NOT recommended for use in
patients with:
athetosis movements.
Huntington's chorea.
parkinsonism.
tardive dyskinesia.




hepatic impairment.
A patient presenting with a transient ischemic attack (TIA) is taking nifedipine
(Adalat CC) for hypertension. Pharmacokinetics of nifedipine may be altered in
patients with:
renal insufficiency.
hepatic impairment.
irritable bowel disease.
G6PD deficiency.




-EXAM
NEURO
QUESTIONS
Exam
PHARM
Q&A
LATEST
(2026/2027)
AND CORRECT
2025 REVISED
| Complete
DETAILED
EXAM
StudyANSWERS
QUESTIONS
Guide & Verified
(VERIFIED
ANDQuestions
CORRECT
COMPLETE
with
DETAILED
Correct
SOLUTION)
AnswersAPEA-
ANSWERS
ALREADY
(VERIFIED
NEURO
PASSED
PHARM
COMPLETE
SCORE
LATEST
A+.pdf=Package
SOLUTION)
2025 REVISED
ALREADY
DealEXAM
(2026/2027)
PASSED
QUESTIONS
SCOREA

,RM
HARM
LATEST
LATEST
Package
20252025
REVISED
Deal
REVISED
(2026/2027)3
EXAMEXAM
QUESTIONS
ofQUESTIONS
37 ANDAND
CORRECT
CORRECT
DETAILED
DETAILED
ANSWERS
ANSWERS
(VERIFIED
(VERIFIED
COMPLETE
COMPLETE
SOLUTION)
SOLUTION)
ALREADY
ALREADY
PASSED
PASSED
SCORE
SCORE
A+.pdf
A+Package




acetylsalicylic acid.
A medication used in a patient with a transient ischemic attack to prevent platelet
aggregation and produce an anti-inflammatory effect in vessels by inhibiting
prostaglandin synthesis is:
acetaminophen.
ibuprofen.
acetylsalicylic acid.
warfarin.




narrow-angle glaucoma.
Carbidopa/levodopa (Sinemet) for the treatment of Parkinson's disease is
contraindicated in patients with:
diabetes.
history of peptic ulcer disease.
narrow-angle glaucoma.
wide-angle glaucoma.




orthostatic hypotension.
During initiation of treatment and escalation of doses, pramipexole (Mirapex) and
other dopamine agonists are known to cause:
akathisia.



-EXAM
NEURO
QUESTIONS
Exam
PHARM
Q&A
LATEST
(2026/2027)
AND CORRECT
2025 REVISED
| Complete
DETAILED
EXAM
StudyANSWERS
QUESTIONS
Guide & Verified
(VERIFIED
ANDQuestions
CORRECT
COMPLETE
with
DETAILED
Correct
SOLUTION)
AnswersAPEA-
ANSWERS
ALREADY
(VERIFIED
NEURO
PASSED
PHARM
COMPLETE
SCORE
LATEST
A+.pdf=Package
SOLUTION)
2025 REVISED
ALREADY
DealEXAM
(2026/2027)
PASSED
QUESTIONS
SCOREA

,RM
HARM
LATEST
LATEST
Package
20252025
REVISED
Deal
REVISED
(2026/2027)4
EXAMEXAM
QUESTIONS
ofQUESTIONS
37 ANDAND
CORRECT
CORRECT
DETAILED
DETAILED
ANSWERS
ANSWERS
(VERIFIED
(VERIFIED
COMPLETE
COMPLETE
SOLUTION)
SOLUTION)
ALREADY
ALREADY
PASSED
PASSED
SCORE
SCORE
A+.pdf
A+Package




gastrointestinal bleeding.
orthostatic hypotension.
thrombocytopenia.




migraine headaches (acute).
Ergotamine alkaloids, such as dihydroergotamine (Migranal), are indicated in the
treatment of:
basilar migraine headaches.
cluster headaches.
migraine headaches (acute).
tension headaches.




ciprofloxacin (Cipro).
Patients who are taking rasagiline (Azilect) for the treatment of Parkinson's
disease should avoid other CYP1A2 inhibitors such as:
ciprofloxacin (Cipro).
clindamycin (Cleocin).
erythromycin base (Ery-Tab)
sulfamethoxazole/trimethoprim (Bactrim).




-EXAM
NEURO
QUESTIONS
Exam
PHARM
Q&A
LATEST
(2026/2027)
AND CORRECT
2025 REVISED
| Complete
DETAILED
EXAM
StudyANSWERS
QUESTIONS
Guide & Verified
(VERIFIED
ANDQuestions
CORRECT
COMPLETE
with
DETAILED
Correct
SOLUTION)
AnswersAPEA-
ANSWERS
ALREADY
(VERIFIED
NEURO
PASSED
PHARM
COMPLETE
SCORE
LATEST
A+.pdf=Package
SOLUTION)
2025 REVISED
ALREADY
DealEXAM
(2026/2027)
PASSED
QUESTIONS
SCOREA